| | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2023 ( Subtotal = $722,442 ) |
| 2023 | 2023 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503 | KENT | USA | Cancer Biology Research | 002 | 5 | 3/15/2023 | NON-COMPETING CONTINUATION | $58,974 |
| 2023 | 2023 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503 | KENT | USA | Cancer Biology Research | 000 | 5 | 12/1/2022 | NON-COMPETING CONTINUATION | $663,468 |
| 2023 | 2022 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503 | KENT | USA | Cancer Biology Research | 001 | 4 | 12/19/2022 | NON-COMPETING CONTINUATION | $0 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2022 ( Subtotal = $722,442 ) |
| 2022 | 2022 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503 | KENT | USA | Cancer Biology Research | 000 | 4 | 12/1/2021 | NON-COMPETING CONTINUATION | $663,467 |
| 2022 | 2022 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503 | KENT | USA | Cancer Biology Research | 001 | 4 | 5/10/2022 | NON-COMPETING CONTINUATION | $58,975 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2021 ( Subtotal = $715,156 ) |
| 2021 | 2021 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503 | KENT | USA | Cancer Biology Research | 001 | 3 | 2/1/2021 | NON-COMPETING CONTINUATION | $35,758 |
| 2021 | 2021 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503 | KENT | USA | Cancer Biology Research | 000 | 3 | 11/24/2020 | NON-COMPETING CONTINUATION | $679,398 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2020 ( Subtotal = $715,156 ) |
| 2020 | 2020 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503 | KENT | USA | Cancer Biology Research | 000 | 2 | 12/2/2019 | NON-COMPETING CONTINUATION | $643,641 |
| 2020 | 2020 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503 | KENT | USA | Cancer Biology Research | 001 | 2 | 1/23/2020 | NON-COMPETING CONTINUATION | $71,515 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2019 ( Subtotal = $735,467 ) |
| 2019 | 2019 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503 | KENT | USA | Cancer Biology Research | 000 | 1 | 12/3/2018 | NEW | $735,467 |
|
|